The House of Delegates spent nearly an hour debating a Senate bill to reduce the copay cap of a thirty-day supply of insulin from 100-dollars to 35-dollars, and sets a hundred-dollar cap for devices. The Senate bill only covered private insurance and left out PEIA, so delegates adopted an amendment to include PEIA.